Brain Health, a new peer-reviewed journal from Genomic Press, launches today with an inaugural issue anchored by an interview with neuroscientist Luísa Pinto of the University of Minho, whose two-decade pursuit of newborn astrocytes has reshaped how the field understands recovery from depression. The journal, edited by Ma-Li Wong, is designed to convene the fields of cognitive reserve, longevity, sleep science, aging biology, nutritional psychiatry, behavioral intervention, neuroimaging, normative data, and the social sciences and humanities around a shared question: how do human brains remain resilient, recover when injured, and stay functional across the longest possible arc of a life?

Psychiatrist and clinical researcher Gonçalo Cotovio, MD, PhD, of the Champalimaud Foundation in Lisbon, argues in a new Genomic Press interview that focal brain lesions offer something the field of psychiatry almost never has: a foothold in causality. By mapping the networks connected to lesions that produce mania or obsessive-compulsive symptoms, Cotovio and collaborators aim to move psychiatry beyond correlation toward mechanisms that can be engaged therapeutically. His program ultimately aims to bring together lesion network mapping of psychiatric disorders with connectivity-guided transcranial magnetic stimulation and has already seeded the first therapeutic TMS trial at his unit.

In a Genomic Psychiatry Interview published on 5 May 2026, Dr. Dilek Colak, Associate Professor of Neuroscience and of Pediatrics at Weill Cornell Medicine, traces her path from a northern Turkish town where a neighbor boy with mental illness watched the other children from his balcony, to a laboratory that now probes how glial cells and RNA regulation shape autism and schizophrenia. Dr. Colak argues that scientific excellence is measured through too narrow a lens, calls for holistic frameworks that honor clinical expertise and locally relevant research, and names a private fear familiar to many parents in science.